Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Diffuse large B-cell lymphoma stage IV
ADR ID BADD_A07156
ADR Hierarchy
01      Blood and lymphatic system disorders
01.15      Lymphomas non-Hodgkin's B-cell
01.15.02      Diffuse large B-cell lymphomas
01.15.02.004      Diffuse large B-cell lymphoma stage IV
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.28      Lymphomas non-Hodgkin's B-cell
16.28.02      Diffuse large B-cell lymphomas
16.28.02.004      Diffuse large B-cell lymphoma stage IV
Description Not Available
MedDRA Code 10012826
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
B-immunoblastic lymphoma (Kiel Classification) stage IV | B-large cell anaplastic Lymphoma (Kiel Classification) stage IV | Centroblastic lymphoma stage IV | Diffuse large B-cell lymphoma stage IV | Diffuse large cell cleaved lymphoma (Working Formulation) stage IV | Diffuse large cell lymphoma (Diffuse large B-cell lymphoma) (Working Formulation) stage IV | Diffuse mixed small and large cell lymphoma (Diffuse large B-cell lymphoma) stage IV | Large cell immunoblastic lymphoma (Diffuse large B-cell lymphoma) (Working Formulation) stage IV | Reticulosarcoma stage IV | Reticulosarcoma, unspecified site, extranodal and solid organ sites | Disseminated diffuse large B-cell lymphoma
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01253Lenalidomide0.000482%
BADD_D01397Mesalamine0.000183%
BADD_D01418Methotrexate0.000171%
BADD_D02105Tacrolimus0.000743%
The 1th Page    1    Total 1 Pages